Emerald Mutual Fund Advisers Trust Cardiff Oncology, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$9.1 - $19.57 $1.76 Million - $3.78 Million	-193,133 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$12.02 - $24.71 $1.69 Million - $3.47 Million	-140,374 Reduced 42.09%	193,133 $3.47 Million
Q3 2020 Oct 28, 2020	BUY	$4.25 - $14.19 $1.42 Million - $4.73 Million	333,507 New	333,507 $4.73 Million

125

25.3M

866K

203K

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $198M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.